UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	At-the-Market Offering	PREFERRED STOCK	COMMON STOCK	COMMON STOCK At-the-Market Offering	ADDITIONAL PAID-IN CAPITAL	ADDITIONAL PAID-IN CAPITAL At-the-Market Offering	ACCUMULATED DEFICIT	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
Beginning balance (in shares) at Dec. 31, 2023			15,000
Beginning balance at Dec. 31, 2023			$ 0
Beginning balance (in shares) at Dec. 31, 2023				29,130,607
Beginning balance at Dec. 31, 2023	$ 21,291			$ 3		$ 418,487		$ (397,198)	$ (1)
Increase (Decrease) in Shareholders' Equity
Net (Loss) Income	(1,731)							(1,731)
Unrealized Gain on Available-for-Sale Investments	25								25
Issuance of common stock, net of offering costs/At-The-Market (in shares)					358,210
Issuance of common stock, net of offering costs/At-The-Market		$ 560					$ 560
Vesting of Restricted Stock Units Issued, net of Taxes Withheld (in shares)				67,657
Fair value of warrant related to debt financing	247					247
Stock-based Compensation	251					251
Ending balance (in shares) at Mar. 31, 2024			15,000
Ending balance at Mar. 31, 2024			$ 0
Ending balance (in shares) at Mar. 31, 2024				29,556,474
Ending balance at Mar. 31, 2024	20,643			$ 3		419,545		(398,929)	24
Beginning balance (in shares) at Dec. 31, 2023			15,000
Beginning balance at Dec. 31, 2023			$ 0
Beginning balance (in shares) at Dec. 31, 2023				29,130,607
Beginning balance at Dec. 31, 2023	21,291			$ 3		418,487		(397,198)	(1)
Increase (Decrease) in Shareholders' Equity
Net (Loss) Income	(1,388)
Reclassification of Realized Gains on Available-for-Sale Debt Investments/Instrument Investments Included in Net Income	(25)
Foreign Currency Translation Adjustments	$ (4)
Ending balance (in shares) at Jun. 30, 2024			15,000
Ending balance at Jun. 30, 2024			$ 0
Ending balance (in shares) at Jun. 30, 2024	31,030,218			31,030,218
Ending balance at Jun. 30, 2024	$ 23,498			$ 3		422,086		(398,586)	(5)
Beginning balance (in shares) at Mar. 31, 2024			15,000
Beginning balance at Mar. 31, 2024			$ 0
Beginning balance (in shares) at Mar. 31, 2024				29,556,474
Beginning balance at Mar. 31, 2024	20,643			$ 3		419,545		(398,929)	24
Increase (Decrease) in Shareholders' Equity
Net (Loss) Income	343							343
Reclassification of Realized Gains on Available-for-Sale Debt Investments/Instrument Investments Included in Net Income	(25)								(25)
Foreign Currency Translation Adjustments	(4)								(4)
Issuance of common stock, net of offering costs/At-The-Market (in shares)					1,350,169
Issuance of common stock, net of offering costs/At-The-Market		$ 2,203					$ 2,203
Vesting of Restricted Stock Units Issued, net of Taxes Withheld (in shares)				123,575
Stock-based Compensation	$ 338					338
Ending balance (in shares) at Jun. 30, 2024			15,000
Ending balance at Jun. 30, 2024			$ 0
Ending balance (in shares) at Jun. 30, 2024	31,030,218			31,030,218
Ending balance at Jun. 30, 2024	$ 23,498			$ 3		422,086		(398,586)	(5)
Beginning balance (in shares) at Dec. 31, 2024	15,000		15,000
Beginning balance at Dec. 31, 2024	$ 0		$ 0
Beginning balance (in shares) at Dec. 31, 2024	34,056,920			34,056,920
Beginning balance at Dec. 31, 2024	$ 32,586			$ 3		430,207		(397,678)	54
Increase (Decrease) in Shareholders' Equity
Net (Loss) Income	(1,515)							(1,515)
Reclassification of Realized Gains on Available-for-Sale Debt Investments/Instrument Investments Included in Net Income	(56)								(56)
Unrealized Gain on Available-for-Sale Investments	62								62
Vesting of Restricted Stock Units Issued, net of Taxes Withheld (in shares)				200,983
Stock-based Compensation	445					445
Ending balance (in shares) at Mar. 31, 2025			15,000
Ending balance at Mar. 31, 2025			$ 0
Ending balance (in shares) at Mar. 31, 2025				34,257,903
Ending balance at Mar. 31, 2025	$ 31,522			$ 3		430,652		(399,193)	60
Beginning balance (in shares) at Dec. 31, 2024	15,000		15,000
Beginning balance at Dec. 31, 2024	$ 0		$ 0
Beginning balance (in shares) at Dec. 31, 2024	34,056,920			34,056,920
Beginning balance at Dec. 31, 2024	$ 32,586			$ 3		430,207		(397,678)	54
Increase (Decrease) in Shareholders' Equity
Net (Loss) Income	(3,007)
Reclassification of Realized Gains on Available-for-Sale Debt Investments/Instrument Investments Included in Net Income	(120)
Foreign Currency Translation Adjustments	$ 0
Issuance of common stock, net of offering costs/At-The-Market (in shares)					0
Ending balance (in shares) at Jun. 30, 2025	15,000		15,000
Ending balance at Jun. 30, 2025	$ 0		$ 0
Ending balance (in shares) at Jun. 30, 2025	34,430,352			34,430,352
Ending balance at Jun. 30, 2025	$ 30,409			$ 3		431,034		(400,685)	57
Beginning balance (in shares) at Mar. 31, 2025			15,000
Beginning balance at Mar. 31, 2025			$ 0
Beginning balance (in shares) at Mar. 31, 2025				34,257,903
Beginning balance at Mar. 31, 2025	31,522			$ 3		430,652		(399,193)	60
Increase (Decrease) in Shareholders' Equity
Net (Loss) Income	(1,492)							(1,492)
Reclassification of Realized Gains on Available-for-Sale Debt Investments/Instrument Investments Included in Net Income	(64)								(64)
Foreign Currency Translation Adjustments	0
Unrealized Gain on Available-for-Sale Investments	61								61
Issuance of common stock, net of offering costs/At-The-Market (in shares)					0
Vesting of Restricted Stock Units Issued, net of Taxes Withheld (in shares)				172,449
Stock-based Compensation	$ 382					382
Ending balance (in shares) at Jun. 30, 2025	15,000		15,000
Ending balance at Jun. 30, 2025	$ 0		$ 0
Ending balance (in shares) at Jun. 30, 2025	34,430,352			34,430,352
Ending balance at Jun. 30, 2025	$ 30,409			$ 3		$ 431,034		$ (400,685)	$ 57